Outsourced Sequencing, Field Programmable Gate Arrays, Tissue Arrays, and Proteomics in the Clinic | GenomeWeb

The March 2004 cover story of Genome Technology focused on a new trend in DNA sequencing: outsourcing. To get the throughput needed for their projects, some researchers began to turn to companies rather than to their institutions' core labs. Since then, next-generation sequencing has exploded onto the scene, bringing even higher throughput with it — and outsourcing is still going strong. At the time of the article, Lark Technologies had just been acquired by Genaissance which was, in turn, bought by Clinical Data in June 2005.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.

Sep
15
Sponsored by
Agilent Technologies

This webinar will discuss a customized protocol for RNA sequencing that was developed enable focused RNAseq analysis of formalin-fixed paraffin-embedded biopsies for biomarker discovery in prostate cancer.